Access cutting-edge mild autonomous cortisol secretion (macs) treatment through this clinical trial at a research site in Dallas. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Dallas location
Preparing your pre-screening questions…
Access mild autonomous cortisol secretion (macs) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related mild autonomous cortisol secretion (macs) treatment provided free
Check if you qualify for this mild autonomous cortisol secretion (macs) clinical trial in Dallas, TX
No-Cost Study Care
Local to Dallas
Convenient for TX residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this study is to learn how two treatments-adrenalectomy (surgical removal of an adrenal gland) and semaglutide (a medication used for weight management)-affect insulin resistance and cortisol regulation in adults with mild autonomous cortisol secretion (MACS). The study will also learn how these treatments impact body composition, blood pressure, cholesterol, inflammation, muscle strength, and quality of life. The main questions the study aims to answer are: 1. Does adrenalectomy or semaglutide improve insulin resistance more in people with MACS? 2. How do these treatments change cortisol patterns and other cardiometabolic risk factors? 3. Do people with MACS respond differently to semaglutide compared to matched adults without MACS? Participants will: 1. Receive either adrenalectomy or semaglutide if they have MACS, or semaglutide if they are matched controls 2. Complete clinic visits and phone visits over about 26-30 weeks 3. Undergo metabolic testing such as blood tests, urine steroid profiling, body composition scans, blood pressure monitoring, muscle strength testing, and questionnaires about health and well-being
Sponsor: University of Texas Southwestern Medical Center
Yes, this clinical trial (NCT07361874) has an active research site in Dallas, TX that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for mild autonomous cortisol secretion (macs) treatment options in Dallas, TX, this clinical trial (NCT07361874) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Dallas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mild autonomous cortisol secretion (macs) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all mild autonomous cortisol secretion (macs) clinical trials near you to find additional studies recruiting in your area.
See all heart attack clinical trials recruiting in Dallas — not just this study.
Browse Heart Attack Trials in Dallas →